Difference between revisions of "Fabry Disease 2011"
From Bioinformatikpedia
(→Cross-references) |
|||
| Line 37: | Line 37: | ||
== Biochemical disease mechanism == |
== Biochemical disease mechanism == |
||
[[Image:Fabry_disease_glycosphingolipid_pathway.png|thumb|right|Glycosphingolipid biosynthesis of Homo sapiens. The disease associated enzyme is highlighted in red.]] |
[[Image:Fabry_disease_glycosphingolipid_pathway.png|thumb|right|Glycosphingolipid biosynthesis of Homo sapiens. The disease associated enzyme is highlighted in red.]] |
||
| + | [[Image:Fabry_disease_alpha_galactosidase_gl3_to_gl2.png|thumb|right|Glycosphingolipid biosynthesis of Homo sapiens. The disease associated enzyme is highlighted in red.]] |
||
=== Cross-references === |
=== Cross-references === |
||
* [http://www.genome.jp/dbget-bin/www_bget?ds:H00125 KEGG: Fabry Disease] |
* [http://www.genome.jp/dbget-bin/www_bget?ds:H00125 KEGG: Fabry Disease] |
||
Revision as of 01:28, 15 May 2011
Contents
Summary
Phenotype
Symptoms
As the effects caused by the enzymatic disfunction summarize over time, the symptoms evolve progressive.
Childhood
- Pain and burning in the hands and feet
- Impaired sweating
- Psychological and social issues
- Low tolerance for exercise
- Eye abnormalities
Adolescence
- Dark red skin rashes (angiokeratomas[1])
- Fatigue
- Gastrointestinal problems
Adulthood
- Heart problems
- Kidney problems
- Nervous system problems
- Hearing problems
Cross-references
See also description of this disease in
- specific link to Wikipedia
- specific link to HGMD
- specific link to OMIM
... (see databases in "resources")
Biochemical disease mechanism
File:Fabry disease alpha galactosidase gl3 to gl2.png
Glycosphingolipid biosynthesis of Homo sapiens. The disease associated enzyme is highlighted in red.
Cross-references
Mutations
Current knowledge about mutations associated with the disease. - Separate into disease causing and neutral mutations. -- These sequence pages will be the starting point for collecting prediction results and result discussions.
